Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00252889
What this trial is testing

Doxil Topotecan Doublet Cancer Study

Who this might be right for
Small Cell Lung CancerPancreatic CancerHead and Neck Cancer+2 more
Christiana Care Health Services 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07126561
What this trial is testing

Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers

Who this might be right for
HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2
University of Chicago 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07701681
What this trial is testing

Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
ESCCGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Sun Yat-sen University 75
Testing effectiveness (Phase 2)Ended earlyNCT01365130
What this trial is testing

Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen

Who this might be right for
EsophagealGastrooesophageal CancerGastric Cancer
howard safran 15
Large-scale testing (Phase 3)UnknownNCT01745107
What this trial is testing

Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;

Who this might be right for
Esophageal NeoplasmEsophageal Cancer TNM Staging Primary Tumor (T) T2Esophageal Cancer TNM Staging Primary Tumor (T) T3+2 more
Chinese Academy of Medical Sciences 240
Not applicableUnknownNCT05109819
What this trial is testing

Esophagus-sparing Radiotherapy for Metastatic Spinal Cord Compression.

Who this might be right for
Metastatic Spinal Cord CompressionRadiation ToxicityEsophagitis+1 more
Herlev Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00209716
What this trial is testing

Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Hokkaido Gastrointestinal Cancer Study Group 30
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Testing effectiveness (Phase 2)UnknownNCT02544737
What this trial is testing

Apatinib for Metastatic Esophageal Cancer.

Who this might be right for
Esophageal CancerMetastatic Esophageal CancerApatinib
Hangzhou Cancer Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00917462
What this trial is testing

Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer

Who this might be right for
Esophageal CancerGastroesophageal Junction Cancer
Memorial Sloan Kettering Cancer Center 35
Large-scale testing (Phase 3)Looking for participantsNCT06338683
What this trial is testing

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Who this might be right for
Advanced CancerOlanzapineProgression Free Survival
Qinghai Red Cross Hospital 230
Testing effectiveness (Phase 2)Study completedNCT00675194
What this trial is testing

Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer

Who this might be right for
Gastric Cancer
Johannes Gutenberg University Mainz 120
Large-scale testing (Phase 3)UnknownNCT02448979
What this trial is testing

Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach

Who this might be right for
Esophageal Cancer
Chinese Academy of Medical Sciences 800
Not applicableStudy completedNCT03461341
What this trial is testing

European iNvestigation of SUrveillance After Resection for Esophageal Cancer

Who this might be right for
Esophageal CancerMetastatic CancerRecurrent Esophageal Cancer+4 more
St. James's Hospital, Ireland 3,000
Large-scale testing (Phase 3)Looking for participantsNCT06022861
What this trial is testing

Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shandong Boan Biotechnology Co., Ltd 510
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07533305
What this trial is testing

Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
QL1706ESCCFirst-line Therapy
The First Affiliated Hospital of Henan University of Science and Technology 50
Not applicableLooking for participantsNCT06757296
What this trial is testing

Endoscopic Conversion of Sleeve Gastrectomy to Single Anastomosis Sleeve-ileal Bypass (SASI) for Gastroesophageal Reflux (GERD), Primary and Secondary Non-responder.

Who this might be right for
Metabolic SyndromeSevere ObesityReflux, Gastroesophageal+1 more
Singapore Health Services 500
Testing effectiveness (Phase 2)Looking for participantsNCT07367516
What this trial is testing

Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 105
Testing effectiveness (Phase 2)Study completedNCT00130689
What this trial is testing

Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer

Who this might be right for
Esophageal CancerGastric CancerNeoplasm Metastasis
Dana-Farber Cancer Institute 43
Large-scale testing (Phase 3)Looking for participantsNCT05677490
What this trial is testing

MFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Who this might be right for
Advanced Esophageal AdenocarcinomaAdvanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma+12 more
Alliance for Clinical Trials in Oncology 382
Next Page